Plymouth-based Esperion Therapeutics Monday announced the results from a Phase 1 study and four preclinical studies for its heart disease drug candidate ETC-1002. Initial results look promising.
By digitally photographing the tiny, hair-like blood vessels in the back of our eyes, researchers can now look directly at how small blood vessels like those that bring blood to the heart respond to air pollution.
Wayne State University physiology assistant professor Patrick J. Mueller has been awarded a $1 million grant from the National Institutes of Health to study how alterations in the brain caused by inactivity may contribute to an individual’s risk of cardiovascular disease.
Royal Oak-based Beaumont Hospitals has received a $3 million gift from Max and Debra Ernst and family to name the Ernst Cardiovascular Center in Memory of Ellen Ernst. The gift will establish a dedicated center […]
A global team of researchers co-led by the University of Michigan School of Public Health has discovered or confirmed 95 regions of the human genome where genetic variants are associated with blood cholesterol and triglyceride […]
Spanking certainly smarts – but could it cause a heart attack? That’s what a provocative new study from Canada seems to suggest. It linked childhood physical abuse with a significantly higher risk for heart disease […]